SEC Filings | Allogene Therapeutics

Filing date	Description	Form	View
Feb 25, 2021	Securities offered to employees pursuant to employee benefit plans	S-8	0001737287-21-000010.pdf 0001737287-21-000010.rtf 0001737287-21-000010.xls View HTML
Feb 23, 2022	Securities offered to employees pursuant to employee benefit plans	S-8	0001737287-22-000015.pdf 0001737287-22-000015.rtf 0001737287-22-000015.xls View HTML
Feb 28, 2023	Securities offered to employees pursuant to employee benefit plans	S-8	0001737287-23-000020.pdf 0001737287-23-000020.rtf 0001737287-23-000020.xls View HTML
Mar 14, 2024	Securities offered to employees pursuant to employee benefit plans	S-8	0001193125-24-068054.pdf 0001193125-24-068054.rtf 0001193125-24-068054.xls View HTML
Oct 22, 2018	Filing by person(s) reporting owned shares of common stock in a public company >5%	SC 13D	0000078003-18-000083.pdf 0000078003-18-000083.rtf 0000078003-18-000083.xls View HTML
Oct 25, 2018	Filing by person(s) reporting owned shares of common stock in a public company >5%	SC 13D	0000903423-18-000570.pdf 0000903423-18-000570.rtf 0000903423-18-000570.xls View HTML
May 15, 2019	An amendment to a SC 13D filing	SC 13D/A	0001140361-19-009204.pdf 0001140361-19-009204.rtf 0001140361-19-009204.xls View HTML
Jul 10, 2020	An amendment to a SC 13D filing	SC 13D/A	0001387131-20-006309.pdf 0001387131-20-006309.rtf 0001387131-20-006309.xls View HTML
Aug 10, 2020	An amendment to a SC 13D filing	SC 13D/A	0001387131-20-007266.pdf 0001387131-20-007266.rtf View HTML
Sep 17, 2021	An amendment to a SC 13D filing	SC 13D/A	0000078003-21-000098.pdf 0000078003-21-000098.rtf 0000078003-21-000098.xls View HTML

Data provided by Kaleidoscope.